Detection, enumeration, identification and complete antimicrobial susceptibility testing of urogenital mycoplasma: SCREENING METHOD NEW GENERATION: “Expanding the scope of treatment options!”
- Extended panel of antibiotics tested (x11)! - 100% compliance with worldwide recommendations!
The MYCOFAST® Screening RevolutioN kit and its Complement MYCOFAST® RevolutioN 2 enable a complete diagnosis in 2 steps for urogenital mycoplasma diagnosis in various clinical specimens. It’s an accurate, cost-effective, easy-to-use colorimetric assay designed for the detection, enumeration, identification and antibiotic susceptibility determination of Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.) from urogenital specimens. The MYCOFAST® Screening approach provides the same results than with the direct method (MYCOFAST® RevolutioN 2) but in an additional 24/48 hours. It can be chosen for economic reasons sometimes, or to reduce operation time on negative specimens. The screening step (MYCOFAST® Screening RevolutioN) allows the detection and differentiation of U.u. and M.h. after 24/48 hours of incubation. In case of a positive result, the second step (Complement MYCOFAST® RevolutioN ATB+) will provide further information.
Extended panel of antibiotics tested, in full compliance with worldwide recommendations
Complete diagnosis in a two-phase approach
Cost-effective screening in 24 hours
The right pathologic threshold tested for each specimen type
Visual, colorimetric reading